- Release Date: 05/08/21 09:52
- Summary: Veyonda Survival Advantage in LuPSMA Therapy Confirmed
- Price Sensitive: Yes
- Download Document 382.78KB
- Forums
- ASX - By Stock
- NOX
- Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed
Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
0.003(4.48%) |
Mkt cap ! $20.45M |
Open | High | Low | Value | Volume |
6.6¢ | 7.0¢ | 6.6¢ | $3.77K | 54.41K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 141114 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 45399 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 141114 | 0.066 |
1 | 30539 | 0.065 |
1 | 100000 | 0.064 |
1 | 77000 | 0.062 |
2 | 31393 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 45399 | 1 |
0.075 | 16806 | 1 |
0.079 | 10000 | 1 |
0.081 | 12345 | 1 |
0.083 | 40000 | 1 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online